Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Intellectual disability syndromic and non-syndromic

Gene: DAG1

Green List (high evidence)

DAG1 (dystroglycan 1)
EnsemblGeneIds (GRCh38): ENSG00000173402
EnsemblGeneIds (GRCh37): ENSG00000173402
OMIM: 128239, Gene2Phenotype
DAG1 is in 12 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Bi-allelic variants in this gene are associated with a range of dystroglycanopathy phenotypes on a spectrum from isolated muscle disease through to severe brain malformations together with muscle disease. ID is part of the phenotypic spectrum of the more severely affected individuals.
Created: 5 Dec 2022, 4:21 a.m. | Last Modified: 5 Dec 2022, 4:21 a.m.
Panel Version: 0.5067

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9

Nicholas Clark (Other)

I don't know

Three homozygotes for the NM_004393.4(DAG1):c.743del p.(Ala248Glufs*19) variant were identified in a consanguineous family. All presented with hydrocephalus. One of these individuals was described as having "severe brain malformations" and the only survivor of the three at time of publication was described as having "profound intellectual disability". Two siblings who were homozygous for the NM_004393.4(DAG1):c.2006G>T p.(Cys669Phe) variant have been reported to have intellectual disability. An individual with cognitive impairment has been reported to be homozygous for the NM_004393.4(DAG1):c.575C>T p.(Thr192Met) variant. Two siblings from a consanguineous family who were reported to have muscular dystrophy-dystroglycanopathy were homozygous for the NM_004393.4(DAG1):c.2326C>T p.(Arg776Cys) variant but were not reported to have intellectual disability. Another individual with dystroglycanopathy who was reported to be compound heterozygous for the NM_004393.4(DAG1):c.222G>A p.(Val74Ile) and the NM_004393.4(DAG1):c.331G>A p.(Asp111Asn) variants was also not reported to have intellectual disability.

Mouse models have indicated that a lack of dystroglycan can result in brain malformations.
Created: 4 Dec 2022, 10:48 p.m. | Last Modified: 4 Dec 2022, 10:48 p.m.
Panel Version: 0.5067

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9

Publications

History Filter Activity

5 Dec 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: dag1 has been classified as Green List (High Evidence).

5 Dec 2022, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: DAG1 were changed from to Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9

5 Dec 2022, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: DAG1 were set to

5 Dec 2022, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: DAG1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

22 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: DAG1 was added gene: DAG1 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert Review Green,Genetic Health Queensland Mode of inheritance for gene: DAG1 was set to Unknown